Goodrx Holdings Inc
NASDAQ:GDRX

Watchlist Manager
Goodrx Holdings Inc Logo
Goodrx Holdings Inc
NASDAQ:GDRX
Watchlist
Price: 4.82 USD -0.21%
Market Cap: 1.7B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one GDRX stock under the Base Case scenario is 12.22 USD. Compared to the current market price of 4.82 USD, Goodrx Holdings Inc is Undervalued by 61%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GDRX Relative Value
Base Case
12.22 USD
Undervaluation 61%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.2
P/S
P/S
Price to Sales
2.2
vs History
91
vs Industry
44
Median 3Y
3
Median 5Y
3.5
Industry
2.3
Forward
2.1
More Details
61.3
P/E
P/E
Price to Earnings
61.3
vs History
21
vs Industry
3
Median 3Y
-48.2
Median 5Y
-49.8
Industry
22
Forward
12.3
More Details
11.6
P/OCF
P/OCF
Price to OCF
11.6
vs History
85
vs Industry
36
Median 3Y
14.5
Median 5Y
17.7
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
14
Median 3Y
25
Median 5Y
37.7
Industry
20
More Details
2.7
P/B
P/B
Price to Book Value
2.7
vs History
71
vs Industry
35
Median 3Y
2.8
Median 5Y
3.6
Industry
2.2
More Details
2.4
EV/S
EV/S
Enterprise Value to Sales
2.4
vs History
81
vs Industry
44
Median 3Y
2.8
Median 5Y
3.5
Industry
2.4
Forward
2.3
More Details
2.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.6
vs History
83
vs Industry
64
Median 3Y
3.1
Median 5Y
3.7
Industry
5
More Details
12.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.7
vs History
71
vs Industry
26
Median 3Y
28.5
Median 5Y
26.2
Industry
11.6
Forward
6.8
More Details
25
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25
vs History
51
vs Industry
16
Median 3Y
29.6
Median 5Y
26.7
Industry
15.9
Forward
8.9
More Details
12.8
EV/OCF
EV/OCF
Enterprise Value to OCF
12.8
vs History
73
vs Industry
36
Median 3Y
13.6
Median 5Y
17.9
Industry
14.3
More Details
24.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
24.3
vs History
63
vs Industry
27
Median 3Y
23.4
Median 5Y
31.1
Industry
18
More Details
2
EV/IC
EV/IC
Enterprise Value to IC
2
vs History
90
vs Industry
37
Median 3Y
2.6
Median 5Y
3
Industry
1.8
More Details

Multiples Across Competitors

GDRX Competitors Multiples
Goodrx Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Goodrx Holdings Inc
NASDAQ:GDRX
1.7B USD 2.2 61.3 12.7 25
US
Veeva Systems Inc
NYSE:VEEV
45.9B USD 16 58.8 49.1 51.7
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
33.9B AUD 177.8 345.3 241.6 241.6
US
Doximity Inc
NYSE:DOCS
11.6B USD 20.5 52.1 44.5 46.5
JP
M3 Inc
TSE:2413
1.2T JPY 4.3 30.3 17.3 20.8
SE
Sectra AB
STO:SECT B
70.3B SEK 33.9 124.8 -154 -154
US
Waystar Holding Corp
NASDAQ:WAY
6.6B USD 6.8 254.4 23.1 49.5
US
Inspire Medical Systems Inc
NYSE:INSP
3.8B USD 4.6 57.7 59.2 69.6
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
266B INR 0 0 0 0
CN
Winning Health Technology Group Co Ltd
SZSE:300253
22.5B CNY 8.9 305.6 100.7 100.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Goodrx Holdings Inc
NASDAQ:GDRX
Average EV/EBITDA: 63.3
12.7
35%
0.4
US
Veeva Systems Inc
NYSE:VEEV
49.1
38%
1.3
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
241.6
38%
6.4
US
Doximity Inc
NYSE:DOCS
44.5
21%
2.1
JP
M3 Inc
TSE:2413
17.3
13%
1.3
SE
Sectra AB
STO:SECT B
Negative Multiple: -154 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
23.1
18%
1.3
US
Inspire Medical Systems Inc
NYSE:INSP
59.2
90%
0.7
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
100.7
48%
2.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Goodrx Holdings Inc
NASDAQ:GDRX
Average EV/EBIT: 72.1
25
59%
0.4
US
Veeva Systems Inc
NYSE:VEEV
51.7
39%
1.3
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
241.6
36%
6.7
US
Doximity Inc
NYSE:DOCS
46.5
22%
2.1
JP
M3 Inc
TSE:2413
20.8
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -154 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
49.5
40%
1.2
US
Inspire Medical Systems Inc
NYSE:INSP
69.6
64%
1.1
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
100.7
47%
2.1

See Also

Summary
GDRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
GDRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GDRX stock valuation using valuation multiples.
Wall Street Estimates
GDRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GDRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 267,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.